-
1
-
-
0025147232
-
The natural history of uveitis
-
R.B. Nussenblatt The natural history of uveitis Int Ophthalmol 14 1990 303 308 (Pubitemid 20350862)
-
(1990)
International Ophthalmology
, vol.14
, Issue.5-6
, pp. 303-308
-
-
Nussenblatt, R.B.1
-
2
-
-
0000009276
-
Epidemiology of uveitis: Incidence and prevalence in a small urban community
-
R.W. Darrell, H.P. Wagener, and L.T. Kurland Epidemiology of uveitis: incidence and prevalence in a small urban community Arch Ophthalmol 68 1962 502 514
-
(1962)
Arch Ophthalmol
, vol.68
, pp. 502-514
-
-
Darrell, R.W.1
Wagener, H.P.2
Kurland, L.T.3
-
4
-
-
0018813271
-
The reported demography and causes of blindness throughout the world
-
H. Goldstein The reported demography and causes of blindness throughout the world Adv Ophthalmol 40 1980 1 99
-
(1980)
Adv Ophthalmol
, vol.40
, pp. 1-99
-
-
Goldstein, H.1
-
5
-
-
3242664767
-
General approach to the uveitis patient and treatment strategies
-
M. Yanoff, J.S. Duker, 3rd ed Mosby St Louis
-
D.J. Forster General approach to the uveitis patient and treatment strategies M. Yanoff, J.S. Duker, Ophthalmology 3rd ed 2008 Mosby St Louis 783 788
-
(2008)
Ophthalmology
, pp. 783-788
-
-
Forster, D.J.1
-
6
-
-
0031793309
-
Outcomes in anterior uveitis associated with the HLA-B27 haplotype
-
DOI 10.1016/S0161-6420(98)99033-9
-
W.J. Power, A. Rodriguez, M. Pedroza-Seres, and C.S. Foster Outcomes in anterior uveitis associated with HLA-B27 haplotype Ophthalmology 105 1998 1646 1651 (Pubitemid 28513515)
-
(1998)
Ophthalmology
, vol.105
, Issue.9
, pp. 1646-1651
-
-
Power, W.J.1
Rodriguez, A.2
Pedroza-Seres, M.3
Foster, C.S.4
-
7
-
-
20444474470
-
Acute anterior uveitis and HLA-B27
-
DOI 10.1016/j.survophthal.2005.04.003, PII S003962570500041X
-
J.H. Chang, P.J. McCluskey, and D. Wakefield Acute anterior uveitis and HLA-B27 Surv Ophthalmol 50 2005 364 388 (Pubitemid 40828227)
-
(2005)
Survey of Ophthalmology
, vol.50
, Issue.4
, pp. 364-388
-
-
Chang, J.H.1
McCluskey, P.J.2
Wakefield, D.3
-
8
-
-
39749198170
-
Methods for identifying long-term adverse effects of treatment in patients with eye diseases: The Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
-
DOI 10.1080/09286580701585892, PII 790914729
-
J.H. Kempen, E. Daniel, and S. Gangaputra Methods for identifying long term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Ophthalmic Epidemiol 15 2008 47 55 (Pubitemid 351311499)
-
(2008)
Ophthalmic Epidemiology
, vol.15
, Issue.1
, pp. 47-55
-
-
Kempen, J.H.1
Daniel, E.2
Gangaputra, S.3
Dreger, K.4
Jabs, D.A.5
Kacmaz, R.O.6
Pujari, S.S.7
Anzaar, F.8
Foster, C.S.9
Helzlsouer, K.J.10
Levy-Clarke, G.A.11
Nussenblatt, R.B.12
Liesegang, T.13
Rosenbaum, J.T.14
Suhler, E.B.15
-
9
-
-
24044463655
-
Standardization of uveitis nomenclature for reporting clinical data: Results of the First International Workshop
-
Standardization of Uveitis Nomenclature (SUN) Working Group
-
Standardization of Uveitis Nomenclature (SUN) Working Group Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop Am J Ophthalmol 140 2005 509 516
-
(2005)
Am J Ophthalmol
, vol.140
, pp. 509-516
-
-
-
10
-
-
75149154565
-
Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Hypopyon in patients with uveitis
-
A. Zaidi, G.S. Ying, and E. Daniel Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Hypopyon in patients with uveitis Ophthalmology 117 2010 366 372
-
(2010)
Ophthalmology
, vol.117
, pp. 366-372
-
-
Zaidi, A.1
Ying, G.S.2
Daniel, E.3
-
11
-
-
70349295653
-
Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Methotrexate for ocular inflammatory diseases
-
S. Gangaputra, C.W. Newcomb, and T.L. Liesegang Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Methotrexate for ocular inflammatory diseases Ophthalmology 116 2009 2188 2198
-
(2009)
Ophthalmology
, vol.116
, pp. 2188-2198
-
-
Gangaputra, S.1
Newcomb, C.W.2
Liesegang, T.L.3
-
12
-
-
56249131741
-
Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Ocular inflammation in Behet disease: Incidence of ocular complications and of loss of visual acuity
-
R.O. Kacmaz, J.H. Kempen, and C. Newcomb Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Ocular inflammation in Behet disease: incidence of ocular complications and of loss of visual acuity Am J Ophthalmol 146 2008 828 836
-
(2008)
Am J Ophthalmol
, vol.146
, pp. 828-836
-
-
Kacmaz, R.O.1
Kempen, J.H.2
Newcomb, C.3
-
13
-
-
77049113738
-
Cyclosporine for ocular inflammatory diseases
-
R.O. Kacmaz, J.H. Kempen, and C. Newcomb Cyclosporine for ocular inflammatory diseases Ophthalmology 117 2010 576 584
-
(2010)
Ophthalmology
, vol.117
, pp. 576-584
-
-
Kacmaz, R.O.1
Kempen, J.H.2
Newcomb, C.3
-
15
-
-
68149112408
-
Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: Retrospective cohort study [report online]
-
Accessed February 21, 2011
-
J.H. Kempen, E. Daniel, and J.P. Dunn Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study [report online] BMJ 339 2009 b2480 http://www.bmj.com/content/339/bmj.b2480.full.pdf Accessed February 21, 2011
-
(2009)
BMJ
, vol.339
, pp. 2480
-
-
Kempen, J.H.1
Daniel, E.2
Dunn, J.P.3
-
16
-
-
0029089556
-
Outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis
-
A. Linssen, and C. Meenken Outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis Am J Ophthalmol 120 1995 351 361
-
(1995)
Am J Ophthalmol
, vol.120
, pp. 351-361
-
-
Linssen, A.1
Meenken, C.2
-
18
-
-
77954296373
-
Adverse effects of smoking on patients with ocular inflammation
-
A. Galor, W. Feuer, and J.H. Kempen Adverse effects of smoking on patients with ocular inflammation Br J Ophthalmol 94 2010 848 853
-
(2010)
Br J Ophthalmol
, vol.94
, pp. 848-853
-
-
Galor, A.1
Feuer, W.2
Kempen, J.H.3
-
20
-
-
0025936573
-
The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27
-
A. Linssen, A. Rothova, and H.A. Valkenburg The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27 Invest Ophthalmol Vis Sci 32 1991 2568 2578
-
(1991)
Invest Ophthalmol Vis Sci
, vol.32
, pp. 2568-2578
-
-
Linssen, A.1
Rothova, A.2
Valkenburg, H.A.3
-
21
-
-
33845258977
-
HLA-B27-associated acute anterior uveitis in the University Referral Centre in North Thailand: Clinical presentation and visual prognosis
-
DOI 10.1136/bjo.2006.099788
-
K. Pathanapitoon, S. Suksomboon, and P. Kunavisarut HLA-B27 associated acute anterior uveitis in the University Referral Centre in North Thailand: clinical presentation and visual prognosis Br J Ophthalmol 90 2006 1448 1450 (Pubitemid 44862557)
-
(2006)
British Journal of Ophthalmology
, vol.90
, Issue.12
, pp. 1448-1450
-
-
Pathanapitoon, K.1
Suksomboon, S.2
Kunavisarut, P.3
Ausayakhun, S.4
Wattananikorn, S.5
Leetrakool, N.6
Rothova, A.7
-
22
-
-
1842423137
-
Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: A study of 175 cases
-
DOI 10.1016/j.ophtha.2003.07.011, PII S016164200301529X
-
D. Monnet, M. Breban, and C. Hudry Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases Ophthalmology 111 2004 802 809 (Pubitemid 38429680)
-
(2004)
Ophthalmology
, vol.111
, Issue.4
, pp. 802-809
-
-
Monnet, D.1
Breban, M.2
Hudry, C.3
Dougados, M.4
Brezin, A.P.5
-
23
-
-
0030067241
-
Clinical features and associated systemic diseases of HLA-B27 uveitis
-
M. Tay-Kearney, B.L. Schwam, and C. Lowder Clinical features and associated systemic diseases of HLA-B27 uveitis Am J Ophthalmol 121 1996 47 56 (Pubitemid 26026080)
-
(1996)
American Journal of Ophthalmology
, vol.121
, Issue.1
, pp. 47-56
-
-
Tay-Kearney, M.-L.1
Schwam, B.L.2
Lowder, C.3
Dunn, J.P.4
Meisler, D.M.5
Vitale, S.6
Jabs, D.A.7
|